Date Title Description PDF
26 Jun 2024 On corporate transactions ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives Download
24 Jun 2024 On business and financial situation ROVI publishes the press release in relation to information and guidance on its strategic plan for expansion and growth Download
08 May 2024 On P&L The Company releases the press release related to the first three months of 2024 financial results Download
08 May 2024 On P&L The Company releases the first three months 2024 financial results presentation Download
25 Apr 2024 On business and financial situation ROVI announces agreement to manufacture pre-filled syringes Download

Pages

Date Title Description PDF
04 Oct 2022 On business and financial situation The Company informs that it has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value.  Download
03 Oct 2022 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2022 Download
29 Jul 2022 Other relevant información On 26 July 2022 the public deed relating to the Company’s share capital decrease was registered with the Commercial Registry of Madrid. Download
27 Jul 2022 On business and financial situation The Company releases the press release related to the first half 2022 financial results   Download
27 Jul 2022 On business and financial situation The Company releases the first half 2022 financial results presentation Download

Pages

Date Title Description PDF
08 Jan 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the fourth quarter of 2017 Download
21 Dec 2017 Préstamos, créditos y avales ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies Download
08 Nov 2017 Información sobre Resultados ROVI releases the press release related to the nine-month period ended 30 September 2017 results Download
08 Nov 2017 Información sobre Resultados ROVI releases the presentation related to the nine-month period ended 30 September 2017 results. Download
24 Oct 2017 Otros sobre negocio y situación financiera The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project. Download

Pages